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Transcaval TIPS in Patients with Failed
Revision of Occluded Previous TIPS
Objective: To determine the feasibility of transcaval transjugular intrahepatic
portosystemic shunt (TIPS) in patients with occluded previous TIPS.
Materials and Methods: Between February 1996 and December 2000 we per-
formed five transcaval TIPS procedures in four patients with recurrent gastric car-
diac variceal bleeding. All four had occluded TIPS, which was between the hepat-
ic and portal vein. The interval between initial TIPS placement and revisional pro-
cedures with transcaval TIPS varied between three and 31 months; one patient
underwent transcaval TIPS twice, with a 31-month interval. After revision of the
occluded shunt failed, direct cavoportal puncture at the retrohepatic segment of
the IVC was attempted.
Results: Transcaval TIPS placement was technically successful in all cases. In
three, tractography revealed slight leakage of contrast materials into hepatic sub-
capsular or subdiaphragmatic pericaval space. There was no evidence of propa-
gation of extravasated contrast materials through the retroperitoneal space or
spillage into the peritoneal space. After the tract was dilated by a bare stent, no
patient experienced trans-stent bleeding and no serious procedure-related com-
plications occurred. After successful shunt creation, variceal bleeding ceased in
all patients.
Conclusion: Transcaval TIPS placement is an effective and safe alternative
treatment in patients with occluded previous TIPS and no hepatic veins suitable
for new TIPS.
t has been reported that transjugular intrahepatic portosystemic shunt
(TIPS) is a useful procedure in the treatment of patients with uncon-
trolled variceal hemorrhage or intractable abdominal ascites resulting
from portal hypertension (1). It is an interventional procedure leading to decompres-
sion of the splanchnic venous system in patients with portal hypertension by creating a
low-resistance channel between an intrahepatic branch of the portal vein and a main
hepatic vein. Although it has gained wide acceptance for the management of portal
hypertension, a number of major problems such as an increased risk of hepatic en-
cephalopathy and a high rate of shunt dysfunction have been associated with the tech-
nique (2 8).
Shunt dysfunction is a consequence of shunt stenosis or occlusion, and can lead to
recurrent bleeding or ascites. Thus, early detection and correction of shunt dysfunction
may improve the secondary patency rate of TIPS. In most patients, TIPS revision is a
safe and effective means of restoring shunt patency and achieving symptomatic relief.
In some cases, however, TIPS patency cannot be restored in the usual way, and a satis-
factory outcome demands aggressive intervention. When standard shunt revision fails
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Iand the hepatic vein cannot be catheterized or is too small
to create a new shunt, a direct shunt between the retrohep-
atic inferior vena cava (IVC) and the portal vein can be
safely performed. In this article, we report our experiences
and evaluate the feasibility of transcaval TIPS in patients
with failed standard shunt revision.
MATERIALS AND  METHODS
Between February 1996 and December 2000, 57 consec-
utive patients with malfunctioning TIPS underwent revi-
sion of previous TIPS (n=36) or new TIPS placement
(n=21) for recurrent gastric cardiac variceal bleeding. Five
transcaval TIPS procedures were subsequently performed
in four patients, in all of whom TIPS between the hepatic
and portal vein was occluded. In all cases, the indication
for initial TIPS was recurrent bleeding from gastric cardiac
varices. All patients, who were men aged 49 58 (mean, 53)
years, were first referred to our department for revision of
a previous shunt. The interval between initial TIPS place-
ment and transcaval TIPS varied between three and 31
months, this latter period representing the interval be-
tween two transcaval TIPS procedures performed in one
patient. In all cases, portal hypertension was due to hepatic
cirrhosis. Three patients had postnecrotic cirrhosis due to
hepatitis B viral infection, and in one, cirrhosis due to alco-
holic liver disease was present (Table 1). According to the
Childs-Pugh classification of hepatocellular disease, at the
time of transcaval TIPS this was class A in one, class B in
three, and class C in one.
All procedures were performed via the right internal
jugular vein, accessed using the standard Seldinger tech-
nique. A 9-F long vascular sheath (Cook Inc., Blooming-
ton, U.S.A.) containing a 9-F dilator was advanced into the
inferior vena cava, and using a 5-F multipurpose catheter
and 0.035-inch hydrophilic guidewire (Terumo, Tokyo,
Japan), previous TIPS were then accessed for recanaliza-
tion. The shunts could not be catheterized, however. After
failed attempts to negotiate a guidewire into the occluded
lumen, stent puncture using a Colapinto transjugular portal
venous access needle was attempted, but this also failed. In
addition, there were no appropriate hepatic veins for new
TIPS, and since it was thus impossible to catheterize the
occluded shunt or hepatic veins for new TIPS creation,
transcaval TIPS was attempted.
Direct cavoportal puncture from the intrahepatic seg-
ment of the inferior vena cava to the portal vein using a
Colapinto transjugular portal venous access needle was at-
tempted. Using the previous TIPS stent as a target, the
needle was advanced through the hepatic parenchyma into
the portal vein under fluoroscopic guidance. After punctur-
ing the vein, a guidewire was advanced through the needle
and manipulated along it and into the splenic vein. The
Colapinto needle was then withdrawn and a 5-F multipur-
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Table 1. Summary of the Five Transcaval TIPS Procedures in Four Patients with Occluded Previous TIPS
Age/ Child-Pugh Site of  Interval to Hepatic
Transcaval TIPS
Patient Sex Class/Cause of Initia Transcaval veins Extravasation Varix PPG* PPG
+ Outcome
Liver Disease TIPS TIPS (months) embolization
1 58/M B/Hepatitis B RHV/ 3 Small Moderate No 28 9 Patent and
RPV asymptommatic at 3
months follow-up
2 52/M B/Hepatitis B RHV/ 5 Small Moderate Yes 25 5 Intact flow at 17
RPV months, occlusion at
20 months follow-up
by Doppler US
3 49/M B/Alcoholism RHV/ 4 Small Absent No NA NA Repeat transcaval
PRPV TIPS 31 months
later
51/M C/Alcoholism 31 Minimal Yes NA 11 Intact flow at 25
months fallow-up by
Doppler US
4 55/M A/Hepatitis B LHV/ 12 Occluded Absent No NA 13 Follow-up loss
LPV
Note.─ : RHV = right hepatic vein, LHV = left hepatic vein, RPV = right portal vein, PRPV = posterior segmental branch of RPV, LPV = left portal vein
PPG* = portal pressure gradient before procedure (mmHg)
PPG
+  = portal pressure gradient after procedure (mmHg)
NA = not availablepose catheter was passed over the guidewire without di-
latation of the parenchymal tract; venography from that
position demonstrated large cardiac varices and occlusion
of the previous TIPS (Fig. 1). Pressure measurements were
obtained, and the portosystemic gradient thus determined.
The guidewire was replaced with an Amplatz extra-stiff
wire (Cook Inc., Bloomington, U.S.A.), the 9-F sheath with
its 9-F dilator was advanced into the portal vein, and the
dilator was withdrawn. The sheath was then retracted over
the wire from the portal vein to the IVC while simultane-
ous contrast material injection through a side-arm adapter
was performed to confirm the parenchymal location of the
tract prior to balloon dilatation (Fig. 2). After evaluating
the puncture site, the parenchymal tract was dilated using
an Ultrathin Diamond balloon catheter 10 mm in diameter
(Medi-Tech/Boston Scientific, Watertown, Mass., U.S.A.)
(Fig. 3), and a 10-mm-diameter Wallstent (Schneider USA,
Minneapolis, Minn., U.S.A.) was deployed. The stent was
then expanded using a 10-mm angioplasty balloon. A 5-F
multipurpose catheter was readvanced into the splenic
vein; venography from this position was performed and
the portosystemic pressure gradient was remeasured.
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Fig. 1. A 52-year-old man with postnecrotic liver cirrhosis and
variceal bleeding. Portal venogram obtained through splenic vein
injection before transcaval TIPS placement shows occluded pre-
vious shunt, which was between the right hepatic and posterior
segmental branch of the right portal vein (small arrows). Note fill-
ing of prominent gastric cardiac varices with gastrorenal shunt
(arrow).
Fig. 2. A 51-year-old man with alcoholic liver cirrhosis who under-
went one standard TIPS and two parallel transcaval TIPS.
After transcaval portal vein puncture, contrast material injection
through a side-arm adapter of a sheath, with simultaneous retrac-
tion of the sheath over the wire, demonstrates slight spillage of
contrast material (arrow).
Fig. 3. A 52-year-old man with postnecrotic liver cirrhosis and
variceal bleeding. Radiograph demonstrates balloon dilatation of
the parenchymal tract (small arrows). Note the extravasation of
contrast materials into hepatic subcapsular or subdiaphragmatic
pericaval space (arrow). Moderate extravasation of contrast ma-
terials is apparent, and an opacified right bile duct is also seen.
Fig. 4. A 52-year-old man with postnecrotic liver cirrhosis and
variceal bleeding. Portal venogram obtained after transcaval stent
placement shows good flow through the stent without opacifica-
tion of gastric cardiac varices, which were embolized with stain-
less coils. Trans-stent extravasation of contrast material was not
apparent. The postprocedural portosystemic pressure gradient
was 5 mmHg.The patients were discharged from hospital 1-2 weeks af-
ter transcaval TIPS and were followed up at 3-month inter-
vals. Doppler ultrasound (US) was performed 3-5 days af-
ter TIPS insertion, and thereafter at 3-month intervals.
RESULTS
Transcaval TIPS was successful in all cases. In all pa-
tients, 10-mm-diameter stents were positioned after bal-
loon dilatation, and no immediate complications were ob-
served. The portosystemic pressure gradient before tran-
scaval TIPS placement was elevated, and direct portal
venography demonstrated prominent gastric cardiac
varices. After placement, the mean pressure gradient
ranged from 5 to 13 mmHg. Although effective portal vein
decompression was achieved, concomitant transcatheter
coil embolization of varices was performed in two cases
because portal venography demonstrated prominent filling
of gastric cardiac varices (Fig. 4). After TIPS placement,
bleeding stopped in all cases and during hospitalization did
not recur. No patient developed encephalopathy.
In three of five cases, simultaneous contrast injection
through a side-arm adapter while the sheath was retracted
from the parenchymal tract demonstrated minimal or mod-
erate extravasation of contrast material (Figs. 2, 3). This
was, however, confined to hepatic subcapsular space or
free space in the pericaval and subdiaphragmatic area, and
it did not change shape. There was no evidence of propa-
gation of extravasated contrast materials through the
retroperitoneal space or spillage into the peritoneal space.
After tract dilatation by deploying a bare stent, no trans-
stent bleeding occurred, and repeated shunt venography
demonstrated good flow through the shunt and no further
extravasation of contrast material (Fig. 4). No serious pro-
cedure-related complications were observed, and blood
pressure changed neither during nor after the procedures.
There was no evidence of internal bleeding after stent
placement, and patients were discharged without incident
one week later.
Using Doppler US, shunt patency was followed up in
three patients. In two of these, shunts were patent 3 and
25 months after transcaval TIPS placement, respectively,
and in the other, Doppler US detected shunt occlusion at
24 months follow-up. In that patient variceal bleeding re-
curred 31 months after previous transcaval TIPS, and a
new, parallel, transcaval TIPS was created (Fig. 2). The
previous shunt was positioned through the right portal
vein; the subsequent transcaval shunt was successfully po-
sitioned through the portal vein near its bifurcation point.
Variceal bleeding in that patient resolved after new TIPS.
One patient died of progressive hepatic failure 20 months
after successful transcaval TIPS placement.
DISCUSSION
TIPS are functionally equivalent to small-bore portocav-
al or mesocaval shunts. One of their disadvantages com-
pared to surgically created portosystemic shunts is an in-
creased risk of shunt failure (4 7), the most common cause
of which is the development of pseudointimal hyperplasia
(8). TIPS stenosis is most commonly located at the hepatic
vein insertion site and is less frequently observed within
the parenchymal tract (5, 9). Some investigators have spec-
ulated that bile extravasation from adjacent transected bile
ducts occurring during TIPS (a bile leak into the shunt)
may stimulate thrombosis or accelerate the process of
pseudointimal hyperplasia within the shunt track and the
hepatic vein that results in TIPS stenosis or occlusion (10
12). LaBerge et al. (10) reported bile staining within shunts
in several explant specimens, suggesting that an inflamma-
tory response to bile may aggravate the hyperplastic re-
sponse. In addition, technical error may also be a cause of
some TIPS stenosis. Inadequate stent length overlap leav-
ing a bare area of liver parenchyma has been shown to be
a cause of shunt occlusion. Stent shortening can also occur
over time, causing the metallic stent to recede into the
parenchymal tract.
Primary one-year TIPS patency rates have been reported
to be 25 66% (5, 13, 14). A two-year incidence of TIPS
dysfunction of up to 90% was reported when invasive he-
modynamic measurement was performed, though with
careful sonographic follow-up and TIPS revision as needed,
the secondary patency rate of TIPS is reported to be as
high as 92% two years after placement (7).
TIPS revision generally involves angioplasty for stenosis
after negotiating the shunt lumen, and more recently has
involved the placement of additional stents (12). This al-
lows not only the restoration of TIPS function, but may al-
so modify the configuration of the shunt in a way that pre-
vents future restenosis. Shunt occlusion is found in 13 16%
of all patients undergoing revision (5, 8, 15). The recanal-
ization of chronically occluded shunts is technically more
difficult than in cases involving a stenosed shunt. If a
guidewire can be advanced through the occluded lumen in-
to the portal vein, the occluded shunt can be recanalized
by angioplasty with or without coaxial placement of a new
stent. When primary guidewire passage through the oc-
cluded shunt fails, direct puncture of the lumen of the stent
may be attempted. If access to the shunt proves impossible,
the creation of an entirely new parallel shunt may be nec-
essary, though in some instances the catheterization of a
different hepatic vein may be difficult or impossible. As in
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porting new TIPS. When the hepatic vein cannot be
catheterized, portal vein puncture at the stump of the he-
patic vein of the previous TIPS or the intrahepatic segment
of the inferior vena cava itself can be attempted.
The concept of a direct portocaval shunt is not new.
Haskal et al. (16) described the creation of an intrahepatic
portocaval shunt between the IVC and the right portal
vein; in their cases the hepatic veins were inadequate be-
cause of the cephalad location of the portal vein bifurca-
tion relative to the hepatic veins. The procedure has also
been described in a patient who lacked hepatic veins capa-
ble of supporting TIPS, in one with Budd-Chiari syndrome,
and in another with occluded previous TIPS (16 18). Other
possible indications for transcaval portosystemic decom-
pression include the need for a transfemoral approach in
which the internal jugular veins or superior vena cava are
thrombosed and the inferior right hepatic vein is inade-
quate for TIPS.
Our cases are examples of portocaval shunt formation in
patients with occluded previous TIPS resulting in or ac-
companying unusable hepatic veins. Most stent stenoses
occur at the hepatic venous end (8), and because small he-
patic veins are more prone to stenosis, transcaval TIPS can
be a solution where the hepatic vein is too small to create
TIPS. It is also a means by which secondary or tertiary
TIPS can be created, regardless of whether hepatic venous
access is possible.
In TIPS, the puncture may on rare occasions enter the
portal vein in an extrahepatic location, and if this is not
recognized, balloon dilatation of the tract will result in por-
tal vein laceration with significant intraperitoneal bleeding.
Under such circumstances, the use of a bare stent to create
a shunt that extends into a portal vein segment not en-
veloped by liver parenchyma can result in potentially fatal
intra-abdominal hemorrhage, a complication that can be
avoided by careful evaluation of the portal vein location
prior to the procedure. The feasibility of direct portocaval
shunt also depends on the existence of a safe route be-
tween the IVC and the portal veins; such a route is provid-
ed when the tract linking these vessels is completely intra-
parenchymal, a location which must be confirmed. Using
the same method as that employed in the evaluation of the
anatomic relationship between the hepatic capsule and the
portal vein segment, we evaluated the safety of the tract
before stent deployment or tract dilatation. This involved
pulling back a sheath or catheter over a safety wire and in-
jecting contrast material through a side-arm adapter. In
three cases in our series, tractography revealed slight leak-
age of contrast materials into either hepatic subcapsular or
subdiaphragmatic pericaval space. For an extended period,
however, the shape of the extravasated contrast materials
was unchanged. Because there was no evidence of propa-
gation of contrast materials through the retroperitoneal
space, or spillage into peritoneal space, the tract was dilat-
ed by deploying a bare stent. Although bridging may be
safer with a covered stent than with a bare one, trans-stent
bleeding did not occur in our cases; because the shunt exits
the retrohepatic IVC at a site that is well invested by the fi-
brous tissue of the retroperitoneum, such bleeding can be
prevented (16).
The retrohepatic inferior vena cava has been measured
in cadaveric studies; the average length in the craniocaudal
dimension of the retrohepatic segment was found to be 6.7
(range, 3.5 10.9) cm (19, 20), and the vessel was totally en-
closed by liver substance in 30% of cases (20). This en-
closed hepatic substance had an average height of 3.2 cm
and an average thickness of 0.7 cm, and in cases where the
IVC was partially exposed, the average thickness of the
nonenclosed IVC posterior wall was 1.0 cm. Those studies
showed that because the tract is entirely intraparenchymal,
ventral wall puncture of the inferior vena cava at this loca-
tion is in most cases safe. In addition, the extravasation of
contrast materials during the transcaval TIPS procedures in
our series indicated that the retroperitoneal space sur-
rounding the IVC may be confined and restricted, and in-
vested by fibrous tissue. Although there was no bleeding
through the porous mesh at the caval end of the stent in
such cases, this hypothesis requires further anatomical in-
vestigation.
McCowan et al. (21) reported a case of cardiac perfora-
tion and tamponade during TIPS placement. The heart
was, presumably, perforated by instrumentation during the
initial phase of the procedure, at which point manipulation
to gain suitable access to the hepatic vein was performed.
To prevent the occurrence of this unusual complication in
transcaval TIPS, it is important that the cavoportal punc-
ture is made at the extracardiac and retrohepatic segment
of the IVC, and cephalad to the portal vein. For this pur-
pose, the cephalad end of the occluded stent can be used as
a reference marker.
The creation of a new shunt becomes increasingly diffi-
cult if a previous TIPS cannot be catheterized and there
are no hepatic veins capable of supporting a new TIPS. In
such instances, direct portocaval shunt creation permits
secondary or tertiary procedures. In our own experience, it
can be safely performed even if a small leak is found at
evaluation of the tract between the IVC and the portal
vein. The use of covered stents may improve the safety of
the transcaval approach to TIPS in the intrahepatic seg-
ment of the IVC and permit the extension of this concept
to the creation of a direct shunt between the extrahepatic
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IVC and the main portal vein.
Although the number of patients in this study was limit-
ed, the favorable results of shunt formation indicate that
transcaval TIPS placement is an effective and safe alterna-
tive treatment in patients with occluded previous TIPS and
no hepatic veins suitable for new TIPS.
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